冠心病患者介入治疗中机械循环辅助治疗进展(4)
[1]Akhondi AB,Lee MS. The use of percutaneous left ventricular assist device in high-risk percutaneous coronary intervention and cardiogenic shock[J]. Reviews in Cardiovascular Medicine,2013,14(2-4):e144.
[2]Pereraa D,Booth J,Thomas M,et al. The Balloon pump-assisted Coronary Intervention Study(BCIS-1):Rationale and design[J]. American Heart Journal,2009,158(6):910.
[3]Andersson H,Sejersten M,Clemmensen P,et al. Prognosis and high-risk complication identification in unselected patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention[J]. International Journal of Cardiovascular Interv entions,2010,12(3):102.
[4]Ferrari M,Kruzliak P,Spiliopoulos K. An insight into short-and longterm mechanical circulatory support systems[J]. Clinical Research in Cardiology,2015,104(2):95-111.
[5]Thiele H,Zeymer U,Neumann FJ,et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock[J]. Indian Heart Journal,2012,367(14):1287-96.
[6]Thiele H,Zeymer U,Neumann FJ,et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II):final 12 month results of a randomised,open-label trial[J]. Lancet,2013,382(9905):1638-45.
[7]中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南(2016)[J]. 中华心血管病杂志,2016,44(5):382-400.
[8]Ibanez B,James S,Agewall S,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)[J]. Eur Heart J,2017 Aug 26.
[9]Van SD,Katz JN,Albert NM,et al. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association[J]. Circulation,2017,5(4):
[10]Cassese S,De WA,Ndrepepa G,et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction without cardiogenic shock. A meta-analysis of randomized trials[J]. American Heart Journal,2012,164(1):58-65.
[11]杨露露,周延军,王小芳,等. 预防性置入IABP对急性心梗心源性休克行急诊介入无复流发生的影响. 医学与哲学,2017,38(128):32-4.
[12]吕晓,牛兆倬,生伟,等. 预防性应用主动脉球囊反搏在高危左主干病变冠状动脉移植手术中的作用[J]. 心肺血管病杂志,2018,37(1):42-4.
[13]Romeo F,Acconcia MC,Sergi D,et al. Lack of intra-aortic balloon pump effectiveness in high -risk percutaneous coronary interventions without cardiogenic shock:a comprehensive meta-analysis of randomised trials and observational studies[J]. Int J Cardiol,2013,167(5):1783-93.
[14]Tsao NW,Shih CM,Yeh JS,et al. Extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock[J]. Journal of Critical Care,2012,27(5):
[15]Mahmoudi M,Hauville C,Jr G M,et al. The impact of intra-aortic balloon counter-pulsation on in-hospital mortality in patients presenting with anterior ST-elevation myocardial infarction without cardiogenic shock[J]. Cardiovascular Revascularization Medicine,2012,13(6):328-30.
[16]Gregoric ID,Bruckner BA,Jacob L,et al. Techniques and complications of TandemHeart ventricular assist device insertion during cardiac procedures[J]. Asaio Journal,2009,55(3):251-4.
[17]Meyns B,Dens J,Sergeant P,et al. Initial experiences with the Impella device in patients with cardiogenic shock-Impella support for cardiogenic shock.[J]. Thoracic & Cardiovascular Surgeon,2003,51(6):312-7.
[18]den Uil CA,Akin S,Jewbali LS,et al. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and metaanalysis[J]. Eur J Cardiothorac Surg,2017.
[19]Dixon SR,Henriques JPS,Mauri L,et al. A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial):Initial U.S. Experience[J]. Jacc Cardiovascular Interventions,2009,2(2):91-6.
[20]Sjauw KD,Konorza T,Erbel R,et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry[J]. Journal of the American College of Cardiology,2009,54(25):2430-4.
[21]Dangas GD,Kini AS,Sharma SK,et al. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT Ⅱ randomized trial)[J]. American Journal of Cardiology,2014,113(2):222-8.
[22]Harmon L,Boccalandro F. Cardiogenic shock secondary to severe acute ischemic mitral regurgitation managed with an Impella 2.5 percutaneous left ventricular assist device[J]. Catheterization &Cardiovascular Interventions,2012,79(7):1129-34.
文章来源:《机械设计》 网址: http://www.jxsjzz.cn/qikandaodu/2021/0518/525.html
上一篇:基于的插管上机患者镇痛镇静研究热点聚类分析
下一篇:如何识别人员反射行为